Kiniksa Pharmaceuticals International, plc (KNSA)
Nasdaq: KNSA · CIK 0001730430 · United States
Every official Kiniksa Pharmaceuticals International, plc filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open KNSA filings
Kiniksa Pharmaceuticals International, plc documents
- Kiniksa Pharmaceuticals International, plc 10-K 2026KNSA 10-K 2026: annual report for fiscal 2026
- Kiniksa Pharmaceuticals International, plc 10-K 2025KNSA 10-K 2025: annual report for fiscal 2025
- Kiniksa Pharmaceuticals International, plc 10-K 2024KNSA 10-K 2024: annual report for fiscal 2024
- Kiniksa Pharmaceuticals International, plc 10-K 2023KNSA 10-K 2023: annual report for fiscal 2023
- Kiniksa Pharmaceuticals International, plc 10-K 2022KNSA 10-K 2022: annual report for fiscal 2022
- Kiniksa Pharmaceuticals International, plc 10-Q 2026KNSA 10-Q 2026: quarterly report for fiscal 2026
- Kiniksa Pharmaceuticals International, plc 10-Q 2025KNSA 10-Q 2025: quarterly report for fiscal 2025
- Kiniksa Pharmaceuticals International, plc 10-Q 2024KNSA 10-Q 2024: quarterly report for fiscal 2024
- Kiniksa Pharmaceuticals International, plc 10-Q 2023KNSA 10-Q 2023: quarterly report for fiscal 2023
- Kiniksa Pharmaceuticals International, plc 10-Q 2022KNSA 10-Q 2022: quarterly report for fiscal 2022
- Kiniksa Pharmaceuticals International, plc 8-K 2026KNSA 8-K 2026: current report for fiscal 2026
- Kiniksa Pharmaceuticals International, plc 8-K 2025KNSA 8-K 2025: current report for fiscal 2025
- Kiniksa Pharmaceuticals International, plc 8-K 2024KNSA 8-K 2024: current report for fiscal 2024
- Kiniksa Pharmaceuticals International, plc 8-K 2023KNSA 8-K 2023: current report for fiscal 2023
- Kiniksa Pharmaceuticals International, plc 8-K 2022KNSA 8-K 2022: current report for fiscal 2022
- Kiniksa Pharmaceuticals International, plc DEF 14A 2026KNSA DEF 14A 2026: proxy statement for fiscal 2026
- Kiniksa Pharmaceuticals International, plc DEF 14A 2025KNSA DEF 14A 2025: proxy statement for fiscal 2025
- Kiniksa Pharmaceuticals International, plc DEF 14A 2024KNSA DEF 14A 2024: proxy statement for fiscal 2024
- Kiniksa Pharmaceuticals International, plc DEF 14A 2023KNSA DEF 14A 2023: proxy statement for fiscal 2023
- Kiniksa Pharmaceuticals International, plc DEF 14A 2022KNSA DEF 14A 2022: proxy statement for fiscal 2022
- Kiniksa Pharmaceuticals International, plc Form 4 2026KNSA Form 4 2026: insider trading filing for fiscal 2026
- Kiniksa Pharmaceuticals International, plc Form 4 2025KNSA Form 4 2025: insider trading filing for fiscal 2025
- Kiniksa Pharmaceuticals International, plc Form 4 2024KNSA Form 4 2024: insider trading filing for fiscal 2024
- Kiniksa Pharmaceuticals International, plc Form 4 2023KNSA Form 4 2023: insider trading filing for fiscal 2023
- Kiniksa Pharmaceuticals International, plc Form 4 2022KNSA Form 4 2022: insider trading filing for fiscal 2022
- Kiniksa Pharmaceuticals International, plc S-1 2026KNSA S-1 2026: registration statement for fiscal 2026
- Kiniksa Pharmaceuticals International, plc S-1 2025KNSA S-1 2025: registration statement for fiscal 2025
- Kiniksa Pharmaceuticals International, plc S-1 2024KNSA S-1 2024: registration statement for fiscal 2024
- Kiniksa Pharmaceuticals International, plc S-1 2023KNSA S-1 2023: registration statement for fiscal 2023
- Kiniksa Pharmaceuticals International, plc S-1 2022KNSA S-1 2022: registration statement for fiscal 2022
- Kiniksa Pharmaceuticals International, plc 13F 2026KNSA 13F 2026: institutional holdings for fiscal 2026
- Kiniksa Pharmaceuticals International, plc 13F 2025KNSA 13F 2025: institutional holdings for fiscal 2025
- Kiniksa Pharmaceuticals International, plc 13F 2024KNSA 13F 2024: institutional holdings for fiscal 2024
- Kiniksa Pharmaceuticals International, plc 13F 2023KNSA 13F 2023: institutional holdings for fiscal 2023
- Kiniksa Pharmaceuticals International, plc 13F 2022KNSA 13F 2022: institutional holdings for fiscal 2022
More companies